BIOMAT Database Logo BIOMAT Database Logo

Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. 1996

C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Allergy & Asthma Centers of Charleston, South Carolina, USA.

Triamcinolone acetonide (TAA) aerosol nasal inhaler has been shown to effectively relieve the symptoms of seasonal allergic rhinitis in adults and adolescents. We conducted a study to evaluate the efficacy and safety of once-daily administration of TAA aerosol nasal inhaler in pediatric patients aged 6 to 11 years with grass seasonal allergic rhinitis. This multicenter, randomized, double-blind, placebo-controlled, parallel-group study enrolled 116 children who were treated with either TAA aerosol nasal inhaler (220 micrograms/d) or placebo once daily for 2 weeks. Patients evaluated the severity of rhinitis symptoms (nasal stuffiness, discharge, sneezing, and itching) daily according to a four-point scale (0 = absent, 1 = mild, 2 = moderate, and 3 = severe). Patients' and physicians' global evaluations of overall treatment efficacy were assessed at the end of the 2-week treatment period. Patients treated with TAA aerosol nasal inhaler had significantly greater reductions in all nasal symptom scores overall and in virtually all symptoms at the end of week 1 and week 2 compared with those in the placebo group. Both patients' and physicians' global evaluations of efficacy favored TAA aerosol nasal inhaler over placebo. This study demonstrated that once-daily administration of 220 micrograms of TAA aerosol nasal inhaler was well tolerated and effectively reduced the symptoms of seasonal allergic rhinitis in pediatric patients.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012621 Seasons Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Seasonal Variation,Season,Seasonal Variations,Variation, Seasonal,Variations, Seasonal

Related Publications

C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Triamcinolone acetonide Aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study.
January 1995, Clinical therapeutics,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis.
March 1990, Annals of allergy,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis.
October 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis.
March 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
A double blind study of triamcinolone acetonide nasal spray in allergic rhinitis.
January 1962, The Journal of allergy,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study.
January 1995, Clinical therapeutics,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Efficacy and safety of beclomethasone dipropionate nasal aerosol in pediatric patients with seasonal allergic rhinitis.
November 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis.
February 1990, Annals of allergy,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
January 2009, American journal of rhinology & allergy,
C H Banov, and W S Silvers, and A W Green, and J H van Bavel, and J A Winder, and G Feiss, and B Simpson, and J A Furst, and J A Smith
Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study.
April 2000, Ear, nose, & throat journal,
Copied contents to your clipboard!